| Date | Title | Description |
| 22.06.2023 | Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction | Sachin M Shridharani, MD, FACS, Steven Dayan, MD, FACS, Brian Biesman, MD, Joel Cohen, MD, Jeanine Downie, MD, Derek Jones, MD, Ava Shamban, MD, Sabrina Fabi, MD, Steve Yoelin, MD, Steven Fagien, MD, FACS, Glynis Ablon, MD, FAAD, Michael Go... |
| 15.06.2023 | IOME Bio’s foundational science, published in Nature, represents significant breakthrough in cancer research | |
| 09.05.2023 | Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder | - |
| 22.03.2023 | SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial | - |
| 14.12.2022 | Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B... | - |
| 08.12.2022 | Canary Medical Announces Introduction of Groundbreaking Orthopedic Analytic Platform
Canary Medical Announces Introduction of Groundbreaking Orthopedic Analytic Platform | - |
| 06.12.2022 | SQZ Biotechnologies Receives FDA Fast Track Designation | - |
| 06.12.2022 | SQZ Biotechnologies Receives FDA Fast Track Designation #3 | - |
| 22.11.2022 | Graybug and CalciMedica Enter into Definitive Merger Agreement | - |
| 12.09.2022 | Volastra Therapeutics Named One of Fierce Biotech’s “Fierce 15” Companies of 2022 | - |
| 12.07.2022 | Medtronic signs $585m option to buy Israeli diagnostic co CathWorks | Global medical device giant Medtronic plc (NYSE:MDT) today announced it has entered into a strategic partnership agreement with Israeli diagnostics company CathWorks. Kfar Saba-based CathWorks has developed a non-invasive diagnostic systems... |
| 21.03.2022 | Volastra Therapeutics Announces Drug Discovery Collaboration with Bristol Myers Squibb | Bristol Myers Squibb to leverage Volastra’s proprietary CINtech platform to discover and develop oncology drug candidates |
| 15.03.2022 | Microbion Corporation Announces Granting of a US Patent for the Use of Topical Pravibismane for Diabetic Foot Ulcer Infections | Extends patent protection for Microbion’s proprietary topical pravibismane
for the treatment of diabetic foot ulcer infections to 2039 |
| 30.08.2021 | Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World’s First and Only Smart Knee Implant | |
| 26.07.2021 | Please wait while your request is being verified... | - |
| 06.04.2021 | Volastra bumps up seed round to $44M, inks Microsoft partnership to tackle cancer metastasis | Metastatic cancer is responsible for most cancer deaths, but people whose disease has spread to other parts of the body don’t have enough effective treatment options. Volastra Therapeutics wants to change that by developing drugs that targe... |
| 11.03.2021 | Nuclear Medicine Prepares for Greater 68Ga Demand | When the US Food and Drug Administration (FDA) approved the use of Gallium-68 prostate-specific membrane antigen (PSMA)-11 (68Ga PSMA-11) PET imaging for prostate cancer in December, nuclear medicine specialists were not the only ones excit... |
| 08.03.2021 | Fierce Medtech Names Canary Medical a “Fierce 15” Company for 2020 | VANCOUVER, BC and CARLSBAD, CA – March 8, 2021 – Canary Medical today announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry. |
| 22.02.2021 | Microbion Corporation Receives Additional Funding Support from the Cystic Fibrosis Foundation to Speed Advancement of Inhaled Pravibismane | – IND-enabling Studies Underway |
| 19.01.2021 | ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets | BURNABY, British Columbia & PETACH TIKVA, Israel–(BUSINESS WIRE)–ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-1... |
| 12.01.2021 | 5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rights | Montreal, Québec and Bozeman, Montana, January 12, 2021 –– 5N Plus Inc. (“5N Plus”), a leading global producer of specialty chemicals and engineered materials, and Microbion Corporation (“Microbion”), a clinical stage pharmaceutical company... |
| 23.12.2020 | Health Canada Approves Cyclotron Produced Technetium-99m Utilizing The ARTMS QIS And Solid Targets | Burnaby, Canada, December 22, 2020 – ARTMS Inc. (ARTMS) is excited to announce Health Canada’s marketing approval of cyclotron produced technetium-99m (99mTc) for clinical use. For the Health Canada submission, ARTMS provided technical expe... |
| 29.10.2020 | SQZ Biotech Announces Pricing of Initial Public Offering | WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ) (“SQZ”) today announced the pricing of its initial public offering of 4,411,765 shares of common stock at a public offering price of $16.00 per share. All of the share... |
| 06.05.2020 | ARTMS and Telix Pharmaceuticals Announce Manufacturing Collaboration | VANCOUVER, British Columbia and MELBOURNE, Australia, May 06, 2020 (GLOBE NEWSWIRE) — ARTMS Products Inc. (ARTMS), a global leader in the development of novel technologies enabling the production of the world’s highest demand diagnostic ima... |
| 04.02.2020 | Precision Medicine Being Advanced Through Data Privacy and Security | - |
| 22.01.2020 | 2020 Could be a Defining Year for SQZ Biotech | |
| 16.01.2020 | How swallowing a star might keep you from missing a dose of medicine | - |
| 04.12.2019 | Once-a-month birth control pill? Experiment works in animals | WASHINGTON (AP) — Birth control pills work great if women remember to take them every day but missing doses can mean a surprise pregnancy. Now scientists have figured out how to pack a month’s supply into one capsule. |
| 19.11.2019 | “Squeezing” Cells Could Transform Cell Therapy Manufacturing | Manufacturing today’s cell therapies remains expensive and complex due to the need for viruses or electric shocks to engineer patient cells. Yescarta®, for example, one of the first CAR-T therapies approved for sale, takes 3-4 weeks to reac... |
| 10.09.2019 | Chuck Conroy Appointed CEO of ARTMS | ANCOUVER, British Columbia–(BUSINESS WIRE)–ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed medical radioisotopes, is pleased to... |
| 01.04.2019 | Science Focus Fuels Successful Process Development for Startups | Getting the science right helps biopharma startups overcome development and commercialization challenges. |
| 16.01.2019 | Drug companies chase deals for cell and gene therapies, biotech’s ‘next wave’ | Bristol-Myers Squibb Co.’s planned takeover of Celgene Corp. is the latest and strongest vote of confidence yet in the burgeoning field of cell and gene therapies, an innovative method of treating — and potentially curing — diseases from ca... |
| 10.12.2018 | Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill | WATERTOWN, Mass., Dec. 10, 2018 (BUSINESS WIRE) – Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for intellectual p... |
| 15.10.2018 | SQZ Biotech Expands Cell Therapy Partnership with Roche to Develop Antigen Presenting Cells for Immune-Oncology | October 15, 2018 – Watertown, MA – SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the expansion of its collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) in c... |
| 13.09.2018 | Supernus to Acquire Biscayne Neurotherapeutics | Adds Phase 1 Novel Epilepsy Development Program |
| 08.08.2018 | SQZ Biotech Completes Oversubscribed $72 Million Series C Financing | SQZ advancing cell therapy pipeline toward clinical trials in multiple indications, Company Board of Directors expands with addition of Marc Elia and Zafi Avnur, PhD. |
| 21.09.2017 | PHEMI Appoints New CEO to Focus on Growth | Incoming CEO, Rick Makos, brings a strong customer-focus and extensive industry expertise, positioning the company for market expansion |
| 19.09.2017 | PhysIQ Wins DPharm IDOL 2017 | PhysIQ, a Chicago-based leader in developing solutions that leverage artificial intelligence (AI) to empower digital health for ambulatory patient monitoring and clinical trial support, was named DPharm Idol 2017 at the 7th annual DPharm: D... |
